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ABSTRACT
Purpose RNA interference (RNAi) is a process by which small
interfering RNAs (siRNA) induce sequence-specific gene silencing.
Therefore, siRNA is an emerging promise as a novel therapeutic.
In order to realize the high expectations for therapeutic
applications, efficient delivery systems for siRNA are necessary.
Methods In this study, a new series of biodegradable poly
(amido amine)s with disulfide linkages in the backbone was
synthesized out of N,N′-cystaminebisacrylamide (CBA), 4-
amino-1-butanol (ABOL) and ethylene diamine (EDA). Effects
of different percentages of butanolic side chains and proto-
natable fragments in the main chain on siRNA complexation,
cellular uptake, gene silencing and toxicity were investigated.
Results Incorporation of EDA in the polymer resulted in
increased siRNA condensation. Efficient siRNA condensation
was shown to be necessary for cellular uptake; however,
excess of polymer decreased siRNA uptake for polymers with
high amounts of EDA. Silencing efficiency did not correlate with
uptake, since silencing increased with increasing w/w ratio for
all polymers. More than 80% knockdown was found for
polyplexes formed with polymers containing 25% or 50%
EDA, which was combined with low cytotoxicity.
Conclusions Poly(amido amine)s with minor fractions of
protonatable fragments in the main chain are promising carriers
for delivery of siRNA.
KEY WORDS delivery . disulfide bonds . poly(amido amine)s .
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INTRODUCTION
RNA interference (RNAi) is an evolutionary conserved process
for post-transcriptional silencing (1,2). Introduction of short
interfering RNA (siRNA) molecules into cells can effectuate
RNAi (3). The technique is currently widely used as a tool in
functional genomics, but it also holds great promise as a
therapeutic strategy, by suppressing the expression of disease-
related genes (4,5). However, since siRNA molecules are
relatively large and highly negatively charged, they are not
readily taken up by cells. Therefore, the development of
efficient and safe delivery systems that deliver siRNA to its site
of action, i.e. the cytoplasm, is essential for therapeutic
activity. These systems should fulfill several requirements,
including the ability to protect siRNA during the extracellular
delivery stage, enhance cellular association and uptake, trigger
endosomal escape and release siRNA in the cytoplasm. For
clinical use, they should furthermore be safe and biodegrad-
able. Current methods for siRNA delivery include viral
vectors, peptides (6), cationic lipids (7), liposomes (8) and
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cationic polymers such as poly(ethylenimine) (PEI) (9) and
poly(L-lysine) (PLL) (10). Although these approaches have all
shown specific advantages and disadvantages, the attractive-
ness of polymers lies in the possibility to be specifically tailored
for different applications. At the same time, the major
drawback of the currently used polymers is their high toxicity,
which is most likely caused by their poor biodegradability.
Recently, a new class of biodegradable cationic polymers
based on poly(amido amine)s with disulfide linkages in the
backbone (SS-PAA polymers) has been developed (11).
These polymers self assemble with plasmid DNA into nano-
sized polyplexes and display efficient gene transfer proper-
ties. Due to the difference in redox potential between the
oxidizing extracellular space and the reducing intracellular
space, the disulfide bonds are stable outside the cell, but are
rapidly cleaved in the cytoplasm. Introduction of disulfide
linkages in the polymer chain has already been shown to
result in increased transfection efficiency, due to an
increased release of DNA from the complexes and
decreased toxicity for this class of polymers (12). From the
SS-PAAs tested by Lin et al., the copolymer of N,N′-
cystaminebisacrylamide (CBA) and 4-amino-1-butanol
(ABOL) showed the best balance between DNA transfec-
tion efficiency and toxicity (12). The origin of the positive
effect of the butanolic side chains of this polymer on
transfection efficiency still has to be elucidated; however, it
has also been found for a similar class of polymers (13).
Although delivery of DNA and siRNA faces the same
challenges, their molecular topography is different, which
highlights different requirements to their respective delivery
systems (14). In this study, CBA was copolymerized besides
ABOL with 1,2-diaminoethane (EDA) as the amine mono-
mer to introduce more positive charges in the polymer
(Fig. 1). This is expected to increase the electrostatic
interactions between polymer and siRNA, resulting in
improved complexation. Copolymers containing different
percentages of butanolic side chains and aminoethyl frag-
ments in the main chain were synthesized and evaluated for
their potential use for siRNA delivery by comparing their
siRNA condensation properties, cellular uptake, gene silenc-
ing efficiency and toxicity.
MATERIALS AND METHODS
siRNAs
siRNAs were chemically synthesized and supplied by
Eurogentec (Maastricht, The Netherlands). The sequence
of epidermal growth factor receptor (EGFR) siRNA was 5′-
GUU-UGC-CAA-GGC-ACG-AGU-AdTdT-3 ′; 3 ′-
dTdTC-AAA-CGG-UUC-CGU-GCU-CAU-5′. For up-
take studies, the 5′-end of the sense strand was modified
with Alexa 488 dye. Negative control siRNA (Eurogentec)
was used for gel retardation assays, size and zeta potential
measurements and cell viability experiments.
Polymer Synthesis and Characterization
The poly(amidoamine) copolymers were synthesized by
Michael addition polymerization reactions as previously
described (12,15). However, the amine monomers 4-amino-
1-butanol (ABOL) and 1,2-diaminoethane (EDA) were
added sequentially to the reaction mixture. This is
necessary, since EDA contains two primary amino groups
and, therefore, in principle, can react four times with
acrylamide moieties in the Michael addition, which results
in branching and formation of networks. By first allowing
all ABOL monomer to react with the acrylamide groups to
form linear prepolymer chains with acrylamide terminal
groups and subsequently adding an equimolar amount of
EDA, branching is prevented as much as possible, since the
primary amines in EDA have a higher reactivity than the
newly formed secondary amines in the polymer chain.
Fig. 1 Synthesis of poly(CBA-ABOL/EDA) copolymers by prepolymerization of CBA with ABOL and subsequently with EDA monomers.
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Therefore, N,N’-cystaminebisacrylamide (CBA) and ABOL
were first prepolymerized in methanol / water (4/1) at 45°
C (Fig. 1). After six days of polymerization, EDA was
added, and after two days, the polymerization was
terminated by addition of an excess of EDA. The product
was purified by ultrafiltration (MWCO 1000, pH 5),
filtered through a 0.45 μm filter and recovered by
lyophilization, and analyzed by 1H NMR and GPC.
Polyplex Formation
For polyplexes at different polymer/siRNA (w/w) ratios,
siRNA and the appropriate amount of polymer solution were
each diluted in HBG (Hepes-Glucose buffer: 20 mM Hepes,
pH 7.4, 5% glucose). Next, the polymer solution was added to
the siRNA solution in an Eppendorf tube, at a volume ratio of
polymer solution to siRNA solution of 4:1. The mixture was
vortexed for 5 s and incubated for 30 min at room
temperature before use. Lipoplexes with Lipofectamine2000
(Invitrogen, Breda, The Netherlands), used as a control, were
prepared at the optimal Lipofectamine2000:siRNA ratio,
according to the manufacturer’s protocol.
Gel Retardation Assay
Polyplexes, containing 125 pmol siRNA, were prepared in
50 μl HBG. Polyplexes were incubated for 1 h at 37°C in
the presence or absence of 5 mM glutathione. Next, 4 μl
6× loading dye (Fermentas) was added to 20 μl of polyplex
solution, and samples were loaded on a 4% agarose gel
containing 0.5 μg/ml ethidium bromide. Electrophoresis
was performed at 90 V for 30 min, after which pictures of
the gel were made under UV-illumination.
Size and ζ-potential Measurements
Polyplexes, containing 200 pmol siRNA, were prepared in
500 μl HBG. Hydrodynamic diameters were determined
using dynamic light scattering on an ALV CGS-3 system
(Malvern Instruments Ltd., Worcestershire, United King-
dom). For ζ- potential measurements, polyplexes were 1:1
diluted in HBG and measured by laser Doppler electro-
phoresis using a Zetasizer Nano-Z (Malvern Instruments
Ltd., Worcestershire, United Kingdom).
Cell Culture
The human head and neck squamous cell carcinoma
(HNSCC) cell line UM-SCC-14 C, abbreviated as 14 C, was
kindly provided by Prof. Dr. G.A.M.S. van Dongen (Depart-
ment ofOtolaryngology,Head andNeck Surgery, VUMedical
Center, Amsterdam, TheNetherlands). Cells were cultivated at
37°C and 5% CO2 in Dulbecco’s Modified Eagle’s medium
(DMEM) containing 3.7 g/liter sodium bicarbonate, 4.5 g/
liter L-glucose and 2 mM L-glutamine, supplemented with
5% (v/v) fetal bovine serum, 100 IU/ml penicillin, 100 μg/ml
streptomycin and 0.25 μg/ml amphotericin B.
Cellular Uptake Measurements
Qualitative Uptake
Fourteen C cells (8×103 per well) were seeded in 12-well
plates on coverslips, 48 h before transfection. Medium was
replaced with serum-free medium, and cells were treated
with 20 μl of different polyplexes, at a final concentration of
66 nM fluorescently labeled siRNA. After 4 h, cells were
washed twice with phosphate-buffered saline (PBS) and
fixed with 4% paraformaldehyde in PBS at room temper-
ature for 30 min. After fixation, cells were washed twice
with PBS, mounted on glass cover slides using FluorSave
(Calbiochem, San Diego, CA, USA) and allowed to air dry
overnight. Cells were then imaged by a Nikon TE2000-U
fluorescent microscope, equipped with a GFP-B filter
(Nikon Benelux, Brussels, Belgium).
Quantitative Uptake
Quantitative uptake of siRNA was determined as previously
described, with minor modifications (16). Fourteen C cells
(1.6×105 cells per well) were seeded in 6-well plates, 24 h
before transfection. Medium was replaced with serum-free
medium, and cells were treated with 400 μl of different
polyplexes, at a final concentration of 66 nM fluorescently
labeled siRNA. After 4 h, cells were put on ice and washed
with PBS, 1 M NaCl and again PBS to remove all non-
internalized complexes (Supplementary Fig. 1). Four-hundred
μl lysis buffer (2% SDS, 1% Triton X-100 in PBS) was added
to solubilize cells and dissociate polyplexes. Cells were lysed
for 1 h on ice, after which the lysate was centrifuged (15 min,
14,000g, 4°C) to remove cell debris. Two-hundred μl of the
supernatant was transferred to a black 96-well plate to measure
fluorescence on aMithras LB 940 (Berthold Technologies, Bad
Wildbad, Germany). A calibration curve of fluorescent siRNA
in lysis buffer was used to calculate the amount of internalized
siRNA. Aliquots (25 μL) of the supernatants were used to
determine the cellular protein content using the Micro BCA™
protein assay (Pierce, Rockford, USA), according to the
instructions of the supplier. The amount of internalized siRNA
was normalized to the amount of protein, and uptake was
calculated as percentage of total siRNA input.
Gene Silencing Experiments
Silencing experiments were performed as previously de-
scribed (17). Fourteen C cells (4×104 cells per well) were
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seeded in 24-well plates, 24 h before transfection. Medium
was replaced with serum-free medium, and cells were
treated with 100 μl of different polyplexes, at a final
concentration of 66 nM anti-EGFR siRNA. After 4 h,
medium was replaced with complete medium, and cells
were incubated for another 48 h. Cells were trypsinized,
washed with cold PBA buffer (0.3% BSA, 0.03% sodium
azide in PBS) and incubated with a specific FITC-labeled
anti-EGFR monoclonal antibody (Santa Cruz Biotechnolo-
gy Inc., Santa Cruz, CA, USA) in 150 μl PBA buffer for
30 min at 4°C. After that, cells were washed twice with cold
PBA buffer and resuspended in 300 μl PBA buffer.
Measurements were taken on a FACSCalibur (Becton &
Dickinson, Mountain View, CA, USA) and analyzed using
WinMDI 2.9 (©1993–2000 Joseph Trotter). In a density plot
representing forward scatter and sideward scatter, whole
cells were gated out, and at least 5,000 cells were counted for
each sample. The mean fluorescent intensity (MFI) served as
a measure of the amount of EGFR present on the cells.
Cell Proliferation Assay
Fourteen C cells (8×103 cells per well) were seeded in 96-
well plates, 24 h before transfection. Medium was replaced
with serum-free medium, and cells were treated with 20 μl
of different polyplexes, at a final concentration of 66 nM
siRNA. After 4 h, medium was replaced with complete
medium, and cells were incubated for 24 h. BrdU reagent
was added to a final concentration of 10 μM, and cells were
cultured for another 24 h. Colorimetric BrdU cell prolif-
eration assay (Roche Applied Science, Penzberg, Germany)
was performed according to the supplier’s instructions.
Statistical Analysis
Results were analyzed using ANOVA with Bonferroni post-
tests to assess statistical significance.
RESULTS AND DISCUSSION
In this study, a new series of poly(amido amine) copolymers
was explored, based on the copolymer of N,N’-cystamine-
bisacrylamide (CBA) and 4-amino-1-butanol (ABOL),
which has recently been shown to efficiently deliver plasmid
DNA to COS-7 cells (12). This polymer was tailored for
siRNA delivery by copolymerizing 1,2-diaminoethane
(EDA) beside ABOL to increase the density of amine
groups in the main chain of the polymer. Since previous
studies have already shown that small changes in the
structure of the polymer can affect the delivery efficiency
(11,18), copolymers containing different percentages of
ABOL and EDA fragments were synthesized. The charac-
teristics of the final polymers, poly(CBA-ABOL/EDA), are
shown in Table I. The compositions of the polymers were
in accordance with the aimed composition, molecular
weights ranged between 1.6 and 11.7 kDa and polydisper-
sity indices were comparable for all polymers.
Polyplex Formation
Formation of polyplexes was confirmed by gel retardation.
When siRNA is efficiently bound to its carrier and subse-
quently shielded from the environment, migration into the gel
is completely retarded. Polyplexes were formed at w/w ratios
0 (naked siRNA) to 48. Results are shown in Fig. 2, left panel.
Poly(CBA-ABOL) could not efficiently encapsulate siRNA.
Only at the highest w/w ratio tested, siRNA was completely
bound to its carrier (Fig. 2A, left panel). As hypothesized,
addition of EDA to the final copolymer resulted in increased
complexation of siRNA at lower w/w ratios. Complete
retardation was achieved at w/w ratios 12 and higher for
polymers with 25% EDA and 6 and higher for polymers with
50% and 75% EDA, respectively (Fig. 2B, C, D, left panel).
Poly(CBA-EDA) showed efficient complexation at w/w ratio
3 and higher (Fig. 2E, left panel). This increased condensa-
tion ability with increasing percentage of EDA in the main
chain of the polymer can be explained by the increased
charge density of the polymer, since, after incorporation of
EDA, increased complexation of siRNA was observed at
lower w/w ratios.
Although for cellular uptake and protection against
nucleases, siRNA has to be complexed, for efficient gene
silencing, siRNA should be completely released from the
complex inside the cell (15,19). One of the micro-
environmental features which has been exploited for
Feed compositiona Obtained compositionb Yield (%)c Mw (kg/mol)
d PDI
ABOL/EDA 100/0 27 4.1 1.4
75/25 80/20 50 11.7 2.4
50/50 56/44 57 7.2 1.9
25/75 30/70 53 3.1 1.6
0/100 45 1.6 1.6




bDetermined by 1H NMR
c After ultrafiltration
dDetermined by GPC
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improving the delivery of nucleic acids is the redox potential
gradient that exists between the extra- and intracellular
environment (20). A high concentration of glutathione (±
5 mM (21)) inside cells causes rapid cleavage of disulfide
bonds. The disulfide bridges in the poly(CBA-ABOL/EDA)
copolymers are also expected to be cleaved in a reductive
environment. To investigate whether this reductive degra-
dation also results in siRNA release from the complex,
polyplexes were incubated for 1 h at 37°C in the presence of
5 mM glutathione, mimicking the intracellular environment,
and subsequently subjected to electrophoresis as described.
As shown in Fig. 2, right panel, cleavage of disulfide bridges
resulted in release of siRNA for all polymers, even at the
highest w/w ratios. These results suggest that siRNA is






- glutathione + glutathione 
Fig. 2 Gel retardation assay of
siRNA polyplexes at w/w ratio
from 0 (siRNA only) to 48, after
1 h incubation in the presence
(right) or absence (left) of 5 mM
glutathione. Polyplexes were built
with polymers containing different
percentages of ABOL/EDA (100/0
(A), 75/25 (B), 50/50 (C), 25/75
(D) and 0/100 (E)).
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effectively condensated (Fig. 2, left panel), but is released
from the complex after successful cellular uptake.
Polyplexes were further characterized by size and ζ-
potential measurements. Polyplexes were formed at w/w 3,
6, 12, 24 and 48. Size and surface charge measurements
are presented in Fig. 3A and B. For all polymers, increasing
the w/w ratio resulted in smaller particles with higher ζ-
potential. Poly(CBA-ABOL) was only able to condense
siRNA into small particles at the higher w/w ratios 24 and
48. Polymers with 25% or 50% EDA instead of ABOL
more efficiently condensed siRNA, resulting in particles
smaller than 200 nm for w/w ratio 6 and higher. For the
copolymers containing 75% or 100% EDA, all polyplexes
formed were smaller than 150 nm. Surface charge
measurements followed the same trend as the size measure-
ments. For all w/w ratios, ζ-potential of the complexes
increased with the amount of EDA in the polymer. For
copolymers containing 75% or 100% EDA, the ζ-potential
of the complexes were all almost equally positively charged
to polyplexes at w/w ratio 3, with ζ-potentials between 20
and 30 mV. Interestingly, for polymers with 50%, 75% and
100% EDA, from w/w ratio 12, 3 and 3 respectively,
addition of more polymer to the final complex did not
result in smaller particles or higher surface charges. This
suggests that from these w/w ratios an excess of ‘free’
polymer was added, which had no effect on the physico-
chemical properties of the final complex.
Cellular Uptake
Cellular uptake is one of the key steps in the process of
siRNA delivery. To assess the ability of the various
polymers to facilitate siRNA internalization, fluorescently
labeled siRNA was used to form polyplexes. First, uptake
was studied using fluorescent microscopy. The medium was
replaced with serum-free medium during the time of
transfection (4 h), as binding of serum proteins to the
polyplexes makes it more difficult to exclusively determine
the effect of polymer composition on its activity. The
fluorescent signal in the cells treated with poly(CBA-ABOL)
complexes was very weak. Only at the highest w/w ratios, few
cells displayed a faint green staining (Fig. 4A). This indicates
that efficient siRNA condensation is a prerequisite for
cellular uptake. Introduction of 25% EDA in the final
polymer resulted in increased uptake of polyplexes at
w/w ratio 12, 24 and 48. Cells displayed a mixture of
discrete green spots and a weaker diffuse green signal,
interpreted as siRNA associated with or released from the
carrier, respectively (19). At the lowest w/w ratios, fluores-
cent intensity was still very low (Fig. 4B). Cells transfected
with polyplexes formed with polymers with 50% or 75%
EDA instead of ABOL showed uptake for all w/w ratios;
however, at the highest w/w ratios, fluorescence was less
intense (Fig. 4C, D). For poly(CBA-EDA), fluorescence could
only be detected in cells treated with polyplexes at the lowest
w/w ratios (Fig. 4E). After uptake of Lipofectamine2000
complexes, used as a control, cells displayed a similar
fluorescent signal (Fig. 4F). For all polymers that showed
uptake, a diffuse fluorescent signal also appeared, suggesting
effective siRNA release from the complexes. Improved
cytosolic availability of siRNA may increase the chance of
effective gene silencing (22).
Although microscopy images suggested efficient release
from the carrier after uptake and showed major differences
in uptake efficiency, the ability of different polymers to
enhance siRNA internalization was also quantitatively
determined. For absolute quantification, fluorescence was
measured in cell lysates, since fluorescent signals located in
endosomes often cannot be detected due to quenching
effects. Furthermore, since complexation of siRNA with
polymer also results in loss of fluorescent signal, 2% sodium
dodecyl sulfate (SDS) was added to the lysis buffer, resulting
A
B
Fig. 3 Particle size (A) and ζ-potential (B) of poly(CBA-ABOL/EDA)/
siRNA polyplexes prepared in 20 mM Hepes + 5% glucose, at w/w ratio
of 3, 6, 12, 24 and 48. Polyplexes were built with polymers containing
different percentages of ABOL/EDA (100/0 (white bars), 75/25 (black,
hatched bars), 50/50 (black bars), 25/75 (white, hatched bars) and 0/100
(white, blocked bars)). Particle size and ζ-potential were determined by
dynamic light scattering and laser Doppler electrophoresis. Results are
reported as mean±SD for 2-3 individual measurements.
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in polyplex dissociation and total signal restoration (data
not shown). Results are shown in Fig. 5. Consistent with the
fluorescent microscopy data, poly(CBA-ABOL) polyplexes
showed very little uptake, even at w/w ratio 48 (0.3% of
input). Higher percentages of EDA in the polymer resulted
in much more effective uptake. For polyplexes formed with
the copolymer containing 75% ABOL and 25% EDA,
uptake increased with increasing w/w ratio to a maximum
of 14%. Surprisingly, for polymers containing 50%, 75% or
100% EDA, polyplexes were most efficiently taken up at
lower w/w ratios, with uptake maxima of 15%, 10% and
7% at w/w 12, 3 and 3, respectively. As mentioned above,
for these polymers complete condensation of siRNA was
established at these w/w ratios. Thus, at higher w/w ratios,
free polymer may have hampered siRNA uptake, and this
effect is expected to be pronounced in the case of polymers
with high charge densities, as was also found in the
fluorescent microscopy pictures (Fig. 4C, D and E). This
is most likely due to shielding of the heparin surface
proteoglycans present on cells by free polymer, resulting in
reduced polyplex association, as has been reported earlier
for PEI-polyplexes (23). Alternatively, as colloidal stability
of the polyplexes increases with increasing w/w ratio,
decreased aggregation of the polyplexes could result in
lower uptake. However, such decreased aggregation at
higher w/w ratio was not observed under the conditions
used in our transfection studies, as is shown for polyplexes
prepared with polymers containing ABOL/EDA ratios of
Fig. 4 Fluorescent microscopy pictures of 14 C cells after treatment with polyplexes at w/w ratio of 3, 6, 12, 24 and 48. Polyplexes were built with
polymers containing different percentages of ABOL/EDA (100/0 (A), 75/25 (B), 50/50 (C), 25/75 (D) and 0/100 (E)). Lipofectamine2000 (F) was used as
a control.
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75/25 and 0/100 (Supplementary Fig. 2). In general,
uptake maxima were comparable to uptake of Lipofect-
amine2000 Lipo-plexes (12%).
Gene Silencing and Toxicity
Silencing experiments were performed on a 14 C carcinoma
cell line, using siRNA against the epidermal growth factor
receptor (EGFR) as an example of a therapeutic target.
EGFR is overexpressed in many tumors and is known to play
a role in cell proliferation, migration, angiogenesis develop-
ment and inhibition of apoptosis (24). Polyplexes were formed
at w/w 3, 6, 12, 24 and 48 for all polymers. As shown in
Fig. 6, for all polymers, increasing the w/w ratio resulted in
decreased expression of EGFR after transfection. This effect
was specifically caused by siRNA against EGFR, as
treatment with the same polyplexes containing negative
control siRNA had no effect on EGFR expression, as shown
for w/w ratio 48 (Fig. 6B). The same amount of polymer
without siRNA also did not decrease EGFR expression
(Supplementary Fig. 3). In contrast to our data on siRNA
uptake (Figs. 4 and 5), for all polymers, maximal silencing
efficiency was obtained at the highest w/w ratio tested.
Therefore, uptake of polyplexes does not seem to be the only
limiting step in the transfection process. Another major
hurdle for transfection is known to be endosomal escape.
These poly(amido amine)s contain amino groups with
different pKas, introducing high buffering capacity for
membrane disruption, either via the proton sponge effect
(25) or conformational changes induced by pH changes (26).
Our results indicate that a certain threshold amount of
polymer is necessary to achieve efficient endosomal escape.
For example, while for the polymer containing 50% ABOL
and 50% EDA siRNA uptake was higher at w/w ratio 12
than at w/w ratio 48, silencing efficiency was much less
(approximately 30% versus 80%, respectively). Likely, the
addition of extra polymer contributed to the overall buffer
capacity of the complexes inside endosomes. Our data
suggest that free polymer, as in the case of polyplexes
formed with polymers containing more than 50% EDA at
the highest w/w ratios, can also have a positive effect on
endosomal escape and subsequent gene silencing. Similar
results have been shown for PEI (27).
Interestingly, striking differences in maximum silencing
efficiency were found between the different copolymers.
Polyplexes formed with polymers containing 25% or 50%
EDA were able to induce >80% EGFR silencing, which was
even slightly better than for Lipofectamine2000 lipoplexes,
the current standard for in vitro siRNA delivery. Only
moderate silencing (approximately 40%) was found for
siRNA formulated with the other polymers. The same trend
was observed when cells were transfected in the presence of
serum. Only treatment with polyplexes prepared at w/w ratio
48 with polymers containing 25% or 50% EDA resulted in
EGFR knockdown, although at higher siRNA concentration
(200 nM) (Supplementary Fig. 4).
For poly(CBA-ABOL) and poly(CBA-EDA) complexes,
only moderate silencing in the absence of serum can be
attributed to their poor uptake (Figs. 4 and 5). On the
contrary, the amount of siRNA that was taken up after
complexation with the polymer containing 75% EDA was
almost equal to the amount taken up after polyplex
formation with the polymers with 25% or 50% EDA
(Fig. 5). Of the three polymers, the first has the highest
amount of amine groups and therefore the strongest
interaction with siRNA. It is likely that, despite reduction
of disulfide bonds in the cytoplasm, the inability to
completely release siRNA limited silencing efficiency for
this polymer. Likewise, of the three bioreducible polymers
that were tested by Christensen et al., the polymer with the
highest charge densities of amines produced the lowest
overall gene expression (15).
Relative cell viability was evaluated by determining the
ability of cells to proliferate after treatment. As show in
Fig. 7, polyplexes from polymers with 0% or 25% EDA
were non-toxic, even at the highest w/w ratios. For the
polymer with 50% EDA, polyplexes reduced cell prolifer-
ation to approximately 50% at w/w ratio 48. Polymers with
75% or 100% EDA were the most toxic, with respectively
40% and 10% viability after treatment with polyplexes at
w/w ratio 24 and only a few percent viable cells at w/w 48. In
general, polyplexes were more toxic at increasing w/w ratio.
Furthermore, increasing the amount of EDA in the polymer
also resulted in decreased cell viability. Toxicity has previously
been shown to be related to charge density of the polymer
(28). Comparing these results with the results from the
Fig. 5 siRNA uptake in 14 C cells. Cells were treated with polyplexes at
w/w ratio of 3, 6, 12, 24 and 48. Polyplexes were built with polymers
containing different percentages of ABOL/EDA (100/0 (white bars), 75/25
(black, hatched bars), 50/50 (black bars), 25/75 (white, hatched bars) and
0/100 (white, blocked bars)). Lipofectamine2000 (LF) was used as a
control. Uptake was reported as mean uptake±SD for n=3–4.
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physicochemical characterization of the complexes, toxicity
might be primarily caused by addition of an excess of
polymer, an observation that is confirmed by other studies
(23). Interestingly, while often transfection efficiency seems to
be correlated to toxicity, in our study the most toxic
polymers were shown to be the least effective.
In the discussion of the results, differences in molecular
weight between the polymers were not taken into account,
although molecular weight has shown to be of influence on
siRNA condensation and toxicity (29). However, the
obtained results can be explained by differences in chemical
composition between the polymers, as complexation effi-
ciency and toxicity correlate with composition of the
polymers, but not with molecular weight.
CONCLUSIONS
In this study, several bioreducible poly(amido amine)
copolymers were tested for their ability to deliver siRNA
to a carcinoma cell line and induce gene silencing. These
copolymers were based on a previously described polymer
poly(CBA-ABOL), which has shown to be able to efficiently
transfect pDNA. Copolymers with different percentages of
EDA and ABOL were synthesized, and the interaction with
relatively small siRNA molecules was studied. As predicted,
poly(CBA-ABOL) was not able to completely condense
siRNA into nano-sized polyplexes, resulting in minor
cellular uptake and gene silencing. Addition of 25% or
50% EDA instead of ABOL to the polymer resulted in
polyplexes from respective w/w ratios of 12 and higher and
6 and higher. These polyplexes were efficiently taken up by
14 C cells. Transfection resulted in effective gene silencing
at higher w/w ratios with only minor toxicity. Polymers
with high percentages of EDA (75% or 100%) formed small
polyplexes from the lowest w/w ratios. Efficient uptake was
only found at low w/w ratios, indicating that an excess of
polymer hindered uptake at higher w/w ratios. However,
uptake of polyplexes with low w/w ratios did not result in
effective gene silencing, probably due to lack of sufficient
polymer to induce endosomal escape.
Taken together, we have shown that introduction of extra
amine groups in the CBA-ABOL polymer increased siRNA
condensation, resulting in complete shielding and smaller,
more positively charged polyplexes at lower w/w ratios.
Only siRNA that was effectively complexed was taken up by
Fig. 7 Percentage of cell proliferation of 14 C cells after treatment with
poly(CBA-ABOL/EDA) / siRNA polyplexes, evaluated using the BrdU
proliferation assay. Polyplexes were built with polymers containing different
percentages of ABOL/EDA (100/0 (white bars), 75/25 (black, hatched
bars), 50/50 (black bars), 25/75 (white, hatched bars) and 0/100 (blocked
bars)). Results are reported as mean±SD for n=3. Statistically significant
differences are denoted by * (p<0.05).
A B
Fig. 6 Gene silencing of EGFR in 14 C cells at a final concentration of 66 nM siRNA. Cells were treated with polyplexes at w/w ratio of 3, 6, 12, 24 and
48 using EGFR siRNA (A) or w/w 48 using negative control siRNA (B). Polyplexes were built with polymers containing different percentages of ABOL/
EDA (100/0 (white bars), 75/25 (black, hatched bars), 50/50 (black bars), 25/75 (white, hatched bars) and 0/100 (white, blocked bars)). Lipofectamine2000
(LF) was used as a control. EGFR expression was analyzed by flow cytometry and reported as mean expression±SD for n=2–6. Statistically significant
differences of polymers containing ABOL/EDA percentages of 75/25 and 50/50 from other polymers are denoted by *.
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cells; however, excess of polymer hindered this process. At
the same time, sufficient amount of polymer was necessary
for endosomal escape. Our data indicate that CBA-ABOL
polymers with a minor amount of EDA are most feasible for
siRNA delivery. In the future, the potential of these polymers
for their use for in vivo siRNA delivery will be evaluated.
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